Skip to main content
Premium Trial:

Request an Annual Quote

Third Wave to Supply Invader System to University of Wisconsin

NEW YORK, Feb 6 – Third Wave Technologies said Tuesday it would supply its Invader SNP detection and gene expression system to the University of Wisconsin, Madison in exchange for rights to commercialize certain discoveries for research, diagnostic, or therapeutic purposes.

" This is yet another initiative to expand the reach of our platform to identify valuable targets that may be useful in identifying the genetic cause of diseases and therapeutic candidates for treatment," Lance Fors, Third Wave CEO, said in a statement.

Fors said he expects the collaboration to help speed up discoveries linking genetics to disease.

Third Wave’s other deals include agreements with Glaxo-SmithKline, Novartis, Pfizer, and the Sanger Center.

The company’s initial public offering is expected to take place by the middle of February.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.